Literature DB >> 6264122

Genome structure of Abelson murine leukemia virus variants: proviruses in fibroblasts and lymphoid cells.

S P Goff, O N Witte, E Gilboa, N Rosenberg, D Baltimore.   

Abstract

We have prepared full-length DNA clones of the Abelson murine leukemia virus (A-MuLV) genome. A specific probe homologous to the central portion of the A-MuLV genome was prepared by nick translation of a subcloned restriction fraction from the cloned DNA. The probe was used to examine the genome structure of several A-MuLV variants. The conclusions are: (i) three viruses coding for Abelson-specific proteins of molecular weight 120,000, 100,000, and 90,000 had genomes indistinguishable in size, suggesting that the shorter proteins are the result of early translational termination; (ii) compared with the genome encoding the 120,000-dalton (120K) protein, a genome coding for a 160K protein was 0.8 kilobase larger in the A-MuLV-specific region; and (iii) a genome coding for a 92K protein had a 700-base pair deletion internal to the coding region. This mutant was transformation defective: its 92K protein lacked the protein kinase activity normally associated with the A-MuLV protein, and cells containing the virus were not morphologically transformed. In addition, we determined the number of A-MuLV proviruses in each of several transformed fibroblast and lymphoid cells prepared by infection in vitro. These experiments show that a single copy of the A-MuLV provirus is sufficient to transform both types of cells and that nonproducer cells generally have only one integrated provirus.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6264122      PMCID: PMC171177     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  24 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  Identification of an Abelson murine leukemia virus-encoded protein present in transformed fibroblast and lymphoid cells.

Authors:  O N Witte; N Rosenberg; M Paskind; A Shields; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1978-05       Impact factor: 11.205

3.  A normal cell protein cross-reactive to the major Abelson murine leukaemia virus gene product.

Authors:  O N Witte; N E Rosenberg; D Baltimore
Journal:  Nature       Date:  1979-10-04       Impact factor: 49.962

4.  Proviruses of avian sarcoma virus are terminally redundant, co-extensive with unintegrated linear DNA and integrated at many sites.

Authors:  S H Hughes; P R Shank; D H Spector; H J Kung; J M Bishop; H E Varmus; P K Vogt; M L Breitman
Journal:  Cell       Date:  1978-12       Impact factor: 41.582

5.  Cells nonproductively transformed by Abelson murine leukemia virus express a high molecular weight polyprotein containing structural and nonstructural components.

Authors:  F H Reynolds; T L Sacks; D N Deobagkar; J R Stephenson
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

6.  The integrated genome of murine leukemia virus.

Authors:  D Steffen; R A Weinberg
Journal:  Cell       Date:  1978-11       Impact factor: 41.582

7.  Virus production by Abelson murine leukemia virus-transformed lymphoid cells.

Authors:  A Shields; N Rosenberg; D Baltimore
Journal:  J Virol       Date:  1979-08       Impact factor: 5.103

8.  High frequency of aberrant expression of Moloney murine leukemia virus in clonal infections.

Authors:  A Shields; W N Witte; E Rothenberg; D Baltimore
Journal:  Cell       Date:  1978-07       Impact factor: 41.582

9.  The effect of helper virus on Abelson virus-induced transformation of lymphoid cells.

Authors:  N Rosenberg; D Baltimore
Journal:  J Exp Med       Date:  1978-04-01       Impact factor: 14.307

10.  A quantitative assay for transformation of bone marrow cells by Abelson murine leukemia virus.

Authors:  N Rosenberg; D Baltimore
Journal:  J Exp Med       Date:  1976-06-01       Impact factor: 14.307

View more
  32 in total

1.  Insertional mutagenesis of the Abelson murine leukemia virus genome: identification of mutants with altered kinase activity and defective transformation ability.

Authors:  R W Rees-Jones; S P Goff
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

2.  Mutation of Tp53 contributes to the malignant phenotype of Abelson virus-transformed lymphoid cells.

Authors:  K C Thome; A Radfar; N Rosenberg
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

3.  Isolation of antibodies for phosphotyrosine by immunization with a v-abl oncogene-encoded protein.

Authors:  J Y Wang
Journal:  Mol Cell Biol       Date:  1985-12       Impact factor: 4.272

4.  Analysis of viral and somatic activations of the cHa-ras gene.

Authors:  C J Tabin; R A Weinberg
Journal:  J Virol       Date:  1985-01       Impact factor: 5.103

5.  Cell lines and peripheral blood leukocytes derived from individuals with chronic myelogenous leukemia display virtually identical proteins phosphorylated on tyrosine residues.

Authors:  R D Huhn; M R Posner; S I Rayter; J G Foulkes; A R Frackelton
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

6.  A membrane-associated, carbohydrate-modified form of the v-abl protein that cannot be phosphorylated in vivo or in vitro.

Authors:  S M Watanabe; N E Rosenberg; O N Witte
Journal:  J Virol       Date:  1984-09       Impact factor: 5.103

7.  A phosphatidylinositol 3-kinase docking site in the cytoplasmic tail of the Jaagsiekte sheep retrovirus transmembrane protein is essential for envelope-induced transformation of NIH 3T3 cells.

Authors:  M Palmarini; N Maeda; C Murgia; C De-Fraja; A Hofacre; H Fan
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

8.  Abelson murine leukemia virus: structural requirements for transforming gene function.

Authors:  A Srinivasan; C Y Dunn; Y Yuasa; S G Devare; E P Reddy; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

9.  Only site-directed antibodies reactive with the highly conserved src-homologous region of the v-abl protein neutralize kinase activity.

Authors:  J B Konopka; R L Davis; S M Watanabe; A S Ponticelli; L Schiff-Maker; N Rosenberg; O N Witte
Journal:  J Virol       Date:  1984-07       Impact factor: 5.103

10.  Transfection of fibroblasts by cloned Abelson murine leukemia virus DNA and recovery of transmissible virus by recombination with helper virus.

Authors:  S P Goff; C J Tabin; J Y Wang; R Weinberg; D Baltimore
Journal:  J Virol       Date:  1982-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.